Skip to main content
Clinical Trials/ISRCTN60282575
ISRCTN60282575
Completed
未知

A clinical study to assess the efficacy of gingivitis treatment of a sodium bicarbonate and pyrophosphate dentifrice

Procter & Gamble (United States)0 sites150 target enrollmentMarch 8, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Mild to moderate gingivitis (gum disease)
Sponsor
Procter & Gamble (United States)
Enrollment
150
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 8, 2021
End Date
September 30, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Procter & Gamble (United States)

Eligibility Criteria

Inclusion Criteria

  • 1\. Give written informed consent prior to study participation and be given a signed copy of their informed consent form;
  • 2\. Be at least 18 years of age and typically use a manual toothbrush
  • 3\. Be in good general health as determined by the investigator/designee based on a review/update of their medical history
  • 4\. Possess a minimum of 20 natural teeth with facial and lingual scorable surfaces
  • 5\. Have a Baseline whole mouth mean MGI score of at least 1\.5 but not more than 2\.5
  • 6\. Have established gingivitis with 10 \- 70 % bleeding sites (sites with a GBI score of 1 or 2\) for baseline whole mouth mean
  • 7\. Agree not to participate in any other oral care study for the duration of this study
  • 8\. Agree not to have any elective dentistry, including dental prophylaxis, until study completion and to report any non\-study dentistry received at any time during the course of this study
  • 9\. Agree to refrain from using any non\-study oral hygiene products for the study duration
  • 10\. Agree to return for all their scheduled visits and to follow all study procedures

Exclusion Criteria

  • 1\. Any condition requiring the need for antibiotic premedication prior to dental procedures
  • 2\. Severe periodontal disease, including but not limited to, purulent exudates, generalized mobility, and/or severe recession
  • 3\. Teeth that are grossly carious, fully crowned, or extensively restored
  • 4\. Active treatment for the following conditions: periodontitis, cancer, or a seizure disorder
  • 5\. Report to be nursing or pregnant, or intend to become pregnant any time during the course of this study
  • 6\. Taking an antibiotic, anti\-inflammatory, anti\-coagulant medications, chlorhexidine mouth rinse or a dental prophylaxis any time within the previous 2 weeks
  • 7\. Have any of the following: orthodontic appliances, removable partial dentures, or peri/oral piercings
  • 8\. Oral/gum surgery within the previous two months
  • 9\. Excessive calculus presence that interferes with the probing examination for Gingival Bleeding Index
  • 10\. Performing any oral hygiene the morning of their Baseline study visit

Outcomes

Primary Outcomes

Not specified

Similar Trials